Semaglutide will lose patent protection in countries such as Brazil, China, and India later this month, and researchers identified 150 countries where it was never patented
This trend is also creating greater demand for nutrition services that incorporate: Precision nutrition CGM-informed nutrition counseling Behavioral coaching guided by real-time biometric feedback Integration of sleep, stress, activity, and recovery data into nutrition care It will become increasingly important for clinicians to help patients critically evaluate nutrition misinformation generated by wellness influencers and AI tools
If you feel the medication has completely stopped working, check our guide on why you are not losing weight on semaglutide
Psychoneuroendocrinology 35(9):13561362
FDA label George JT, et al
Los agonistas GLP-1 estn contraindicados en: Hipersensibilidad al frmaco